A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis
Clinical trial NCT05300932 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05300932
- Sponsor
- Tongji Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2026-08-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.